The demand for therapeutic apheresis is estimated to rise at a CAGR of 6.8% during the forecast period. The global therapeutic apheresis market share is projected to be valued at US$ 2,717.9 million in 2023 and is expected to reach US$ 5,264.4 million by 2033.
The demand for therapeutic apheresis is surging owing to growing incidences of chronic diseases and an increasing number of trauma and injury cases.
Apheresis is a procedure wherein blood is withdrawn from a donor’s body, extraction of one or more blood components such as platelets, plasma, and white blood cells, and transfusing of the remaining blood back into the donor during the procedure or at the end of it. Therapeutic apheresis is a process of removing blood components from a patient with apheresis technology.
Therapeutic apheresis is used for removing defective cells. It is also used for the treatment of conditions in which a component or a pathogenic substance in the blood causes morbidity.
Basically, there are three types of therapeutic apheresis procedures used, namely therapeutic plasma exchange (TPE), red blood cell exchange (RBCX), and cellular depletion. Therapeutic plasma exchange is the elimination of a huge volume of plasma from the patient and replacing the plasma with suitable fluids. TPE is commonly used for the treatment of autoimmune diseases or immune-mediated diseases or disorders.
TPE removes paraproteins, monoclonal antibiotics, antigen-antibody, and autoimmune antibody complexes. Therapeutic apheresis particularly removes the significant proportion of one or more components causing diseases.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Attributes | Value |
---|---|
Therapeutic Apheresis Market Size (2023) | US$ 2,717.9 million |
Therapeutic Apheresis Market Projected Size (2033) | US$ 5,264.4 million |
Therapeutic Apheresis Market CAGR (2023 to 2033) | 6.8% |
Rental model’s installation of apheresis devices, strict donor recruitment criteria, and decreased blood donations using apheresis as a result of lack of awareness are likely to restrict the market further over the forecast period.
Countries | Market Share (2022) |
---|---|
United States | 28.8% |
Germany | 6.3% |
Japan | 4.2% |
North America accounted for the leading share, i.e. 32.6% market share in 2022. Factors like growing demand for plasma-derived medicines production and well-established healthcare infrastructure. This region has smooth accessibility to advanced blood collection technologies. It also has the presence of some of the significant apheresis companies in the region.
Additionally, reasons such as soaring initiatives by the government towards blood donation coupled with the rising need for blood components across the globe. Moreover, approval of the latest indications for apheresis treatment, such as acute disseminated encephalomyelitis, autoimmune haemolytic anemia, and neonatal cardiac lupus, support the growth of the market in this region.
In 2022, Europe accounted for 29.8% market share in the global market, owing to the growing prevalence of blood disorders such as profuse bleeding and a decrease in platelet count.
This region witnessed increasing cases of chronic diseases such as autoimmune diseases and cancer, and a growing number of organ donors also is supporting the growth of the market in this region.
The escalation in the rate of occurrence of chronic diseases, growing necessity for plasma sources, additional activities considering blood safety, and an increasing number of complicated surgical procedures are also fuelling the Europe therapeutic apheresis sector.
In June 2022, BioCaptiva raised nearly US$ 2.6 million in the latest seed funding to additionally develop its BioCaptis instrument which is an apheresis-based cell-free DNA capture device for using liquid biopsy testing. The financial round was led by existing investor Archangels, who joined Scottish Enterprise, Cancer Research Horizons, and novel investor Old College Capital.
Key Players Benchmarking The Therapeutic Apheresis Industry
The market has an oligopolistic structure and is characterized by frequent mergers and acquisitions. Industry companies frequently employ new product development and strategic partnerships as sustainability strategies.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The Therapeutic Apheresis Market CAGR for 2033 is 5.2%.
The market is estimated to reach US$ 5,264.4 million by 2033.
Key market players in the Therapeutic Apheresis Market are Terumo BCT, Inc., Fresenius SE & Co. KGaA, and Haemonetics Corporation.
The market is estimated to secure a valuation of US$ 2,717.9 million in 2023.
The market for apheresis is being driven by an increase in chronic disorders. Personal apheresis is expanding with new technology and home use. Patient security is a top priority.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Procedure Types 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Procedure Types, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Procedure Types, 2023 to 2033 5.3.1. Therapeutic Plasma Exchange (TPE) 5.3.2. Red Blood Cell Exchange (RBCX) 5.3.3. Cellular Depletions 5.4. Y-o-Y Growth Trend Analysis By Procedure Types, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Procedure Types, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Technology 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Technology, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technology, 2023 to 2033 6.3.1. Centrifugation 6.3.2. Membrane filtration 6.4. Y-o-Y Growth Trend Analysis By Technology, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Technology, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033 7.3.1. Hematology 7.3.2. Neurology 7.3.3. Nephrology 7.3.4. Rheumatology 7.3.5. Oncology 7.3.6. Others 7.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022 8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033 8.3.1. Hospitals 8.3.2. Blood Banks 8.3.3. Specialty Clinics 8.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022 8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 9.3.1. North America 9.3.2. Latin America 9.3.3. Western Europe 9.3.4. Eastern Europe 9.3.5. South Asia and Pacific 9.3.6. East Asia 9.3.7. Middle East and Africa 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. USA 10.2.1.2. Canada 10.2.2. By Procedure Types 10.2.3. By Technology 10.2.4. By Application 10.2.5. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Procedure Types 10.3.3. By Technology 10.3.4. By Application 10.3.5. By End User 10.4. Key Takeaways 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Procedure Types 11.2.3. By Technology 11.2.4. By Application 11.2.5. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Procedure Types 11.3.3. By Technology 11.3.4. By Application 11.3.5. By End User 11.4. Key Takeaways 12. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. UK 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Rest of Western Europe 12.2.2. By Procedure Types 12.2.3. By Technology 12.2.4. By Application 12.2.5. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Procedure Types 12.3.3. By Technology 12.3.4. By Application 12.3.5. By End User 12.4. Key Takeaways 13. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. Poland 13.2.1.2. Russia 13.2.1.3. Czech Republic 13.2.1.4. Romania 13.2.1.5. Rest of Eastern Europe 13.2.2. By Procedure Types 13.2.3. By Technology 13.2.4. By Application 13.2.5. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Procedure Types 13.3.3. By Technology 13.3.4. By Application 13.3.5. By End User 13.4. Key Takeaways 14. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. India 14.2.1.2. Bangladesh 14.2.1.3. Australia 14.2.1.4. New Zealand 14.2.1.5. Rest of South Asia and Pacific 14.2.2. By Procedure Types 14.2.3. By Technology 14.2.4. By Application 14.2.5. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Procedure Types 14.3.3. By Technology 14.3.4. By Application 14.3.5. By End User 14.4. Key Takeaways 15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. China 15.2.1.2. Japan 15.2.1.3. South Korea 15.2.2. By Procedure Types 15.2.3. By Technology 15.2.4. By Application 15.2.5. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Procedure Types 15.3.3. By Technology 15.3.4. By Application 15.3.5. By End User 15.4. Key Takeaways 16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 16.2.1. By Country 16.2.1.1. GCC Countries 16.2.1.2. South Africa 16.2.1.3. Israel 16.2.1.4. Rest of MEA 16.2.2. By Procedure Types 16.2.3. By Technology 16.2.4. By Application 16.2.5. By End User 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Procedure Types 16.3.3. By Technology 16.3.4. By Application 16.3.5. By End User 16.4. Key Takeaways 17. Key Countries Market Analysis 17.1. USA 17.1.1. Pricing Analysis 17.1.2. Market Share Analysis, 2022 17.1.2.1. By Procedure Types 17.1.2.2. By Technology 17.1.2.3. By Application 17.1.2.4. By End User 17.2. Canada 17.2.1. Pricing Analysis 17.2.2. Market Share Analysis, 2022 17.2.2.1. By Procedure Types 17.2.2.2. By Technology 17.2.2.3. By Application 17.2.2.4. By End User 17.3. Brazil 17.3.1. Pricing Analysis 17.3.2. Market Share Analysis, 2022 17.3.2.1. By Procedure Types 17.3.2.2. By Technology 17.3.2.3. By Application 17.3.2.4. By End User 17.4. Mexico 17.4.1. Pricing Analysis 17.4.2. Market Share Analysis, 2022 17.4.2.1. By Procedure Types 17.4.2.2. By Technology 17.4.2.3. By Application 17.4.2.4. By End User 17.5. Germany 17.5.1. Pricing Analysis 17.5.2. Market Share Analysis, 2022 17.5.2.1. By Procedure Types 17.5.2.2. By Technology 17.5.2.3. By Application 17.5.2.4. By End User 17.6. UK 17.6.1. Pricing Analysis 17.6.2. Market Share Analysis, 2022 17.6.2.1. By Procedure Types 17.6.2.2. By Technology 17.6.2.3. By Application 17.6.2.4. By End User 17.7. France 17.7.1. Pricing Analysis 17.7.2. Market Share Analysis, 2022 17.7.2.1. By Procedure Types 17.7.2.2. By Technology 17.7.2.3. By Application 17.7.2.4. By End User 17.8. Spain 17.8.1. Pricing Analysis 17.8.2. Market Share Analysis, 2022 17.8.2.1. By Procedure Types 17.8.2.2. By Technology 17.8.2.3. By Application 17.8.2.4. By End User 17.9. Italy 17.9.1. Pricing Analysis 17.9.2. Market Share Analysis, 2022 17.9.2.1. By Procedure Types 17.9.2.2. By Technology 17.9.2.3. By Application 17.9.2.4. By End User 17.10. Poland 17.10.1. Pricing Analysis 17.10.2. Market Share Analysis, 2022 17.10.2.1. By Procedure Types 17.10.2.2. By Technology 17.10.2.3. By Application 17.10.2.4. By End User 17.11. Russia 17.11.1. Pricing Analysis 17.11.2. Market Share Analysis, 2022 17.11.2.1. By Procedure Types 17.11.2.2. By Technology 17.11.2.3. By Application 17.11.2.4. By End User 17.12. Czech Republic 17.12.1. Pricing Analysis 17.12.2. Market Share Analysis, 2022 17.12.2.1. By Procedure Types 17.12.2.2. By Technology 17.12.2.3. By Application 17.12.2.4. By End User 17.13. Romania 17.13.1. Pricing Analysis 17.13.2. Market Share Analysis, 2022 17.13.2.1. By Procedure Types 17.13.2.2. By Technology 17.13.2.3. By Application 17.13.2.4. By End User 17.14. India 17.14.1. Pricing Analysis 17.14.2. Market Share Analysis, 2022 17.14.2.1. By Procedure Types 17.14.2.2. By Technology 17.14.2.3. By Application 17.14.2.4. By End User 17.15. Bangladesh 17.15.1. Pricing Analysis 17.15.2. Market Share Analysis, 2022 17.15.2.1. By Procedure Types 17.15.2.2. By Technology 17.15.2.3. By Application 17.15.2.4. By End User 17.16. Australia 17.16.1. Pricing Analysis 17.16.2. Market Share Analysis, 2022 17.16.2.1. By Procedure Types 17.16.2.2. By Technology 17.16.2.3. By Application 17.16.2.4. By End User 17.17. New Zealand 17.17.1. Pricing Analysis 17.17.2. Market Share Analysis, 2022 17.17.2.1. By Procedure Types 17.17.2.2. By Technology 17.17.2.3. By Application 17.17.2.4. By End User 17.18. China 17.18.1. Pricing Analysis 17.18.2. Market Share Analysis, 2022 17.18.2.1. By Procedure Types 17.18.2.2. By Technology 17.18.2.3. By Application 17.18.2.4. By End User 17.19. Japan 17.19.1. Pricing Analysis 17.19.2. Market Share Analysis, 2022 17.19.2.1. By Procedure Types 17.19.2.2. By Technology 17.19.2.3. By Application 17.19.2.4. By End User 17.20. South Korea 17.20.1. Pricing Analysis 17.20.2. Market Share Analysis, 2022 17.20.2.1. By Procedure Types 17.20.2.2. By Technology 17.20.2.3. By Application 17.20.2.4. By End User 17.21. GCC Countries 17.21.1. Pricing Analysis 17.21.2. Market Share Analysis, 2022 17.21.2.1. By Procedure Types 17.21.2.2. By Technology 17.21.2.3. By Application 17.21.2.4. By End User 17.22. South Africa 17.22.1. Pricing Analysis 17.22.2. Market Share Analysis, 2022 17.22.2.1. By Procedure Types 17.22.2.2. By Technology 17.22.2.3. By Application 17.22.2.4. By End User 17.23. Israel 17.23.1. Pricing Analysis 17.23.2. Market Share Analysis, 2022 17.23.2.1. By Procedure Types 17.23.2.2. By Technology 17.23.2.3. By Application 17.23.2.4. By End User 18. Market Structure Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Market Share Analysis of Top Players 18.3.1. By Regional 18.3.2. By Procedure Types 18.3.3. By Technology 18.3.4. By Application 18.3.5. By End User 19. Competition Analysis 19.1. Competition Deep Dive 19.1.1. Asahi Kasei Medical Co. 19.1.1.1. Overview 19.1.1.2. Product Portfolio 19.1.1.3. Profitability by Market Segments 19.1.1.4. Sales Footprint 19.1.1.5. Strategy Overview 19.1.1.5.1. Marketing Strategy 19.1.2. Haemonetics Corporation 19.1.2.1. Overview 19.1.2.2. Product Portfolio 19.1.2.3. Profitability by Market Segments 19.1.2.4. Sales Footprint 19.1.2.5. Strategy Overview 19.1.2.5.1. Marketing Strategy 19.1.3. Miltenyi Biotec 19.1.3.1. Overview 19.1.3.2. Product Portfolio 19.1.3.3. Profitability by Market Segments 19.1.3.4. Sales Footprint 19.1.3.5. Strategy Overview 19.1.3.5.1. Marketing Strategy 19.1.4. Cerus Corporation 19.1.4.1. Overview 19.1.4.2. Product Portfolio 19.1.4.3. Profitability by Market Segments 19.1.4.4. Sales Footprint 19.1.4.5. Strategy Overview 19.1.4.5.1. Marketing Strategy 19.1.5. Terumo BCT Inc. 19.1.5.1. Overview 19.1.5.2. Product Portfolio 19.1.5.3. Profitability by Market Segments 19.1.5.4. Sales Footprint 19.1.5.5. Strategy Overview 19.1.5.5.1. Marketing Strategy 19.1.6. Fresenius Kabi USA 19.1.6.1. Overview 19.1.6.2. Product Portfolio 19.1.6.3. Profitability by Market Segments 19.1.6.4. Sales Footprint 19.1.6.5. Strategy Overview 19.1.6.5.1. Marketing Strategy 19.1.7. Terumo Bct 19.1.7.1. Overview 19.1.7.2. Product Portfolio 19.1.7.3. Profitability by Market Segments 19.1.7.4. Sales Footprint 19.1.7.5. Strategy Overview 19.1.7.5.1. Marketing Strategy 19.1.8. B. Braun Melsungen AG 19.1.8.1. Overview 19.1.8.2. Product Portfolio 19.1.8.3. Profitability by Market Segments 19.1.8.4. Sales Footprint 19.1.8.5. Strategy Overview 19.1.8.5.1. Marketing Strategy 19.1.9. Nikkiso Co. Ltd. 19.1.9.1. Overview 19.1.9.2. Product Portfolio 19.1.9.3. Profitability by Market Segments 19.1.9.4. Sales Footprint 19.1.9.5. Strategy Overview 19.1.9.5.1. Marketing Strategy 19.1.10. Medica S.p.A. 19.1.10.1. Overview 19.1.10.2. Product Portfolio 19.1.10.3. Profitability by Market Segments 19.1.10.4. Sales Footprint 19.1.10.5. Strategy Overview 19.1.10.5.1. Marketing Strategy 19.1.11. Baxter Healthcare Corporation 19.1.11.1. Overview 19.1.11.2. Product Portfolio 19.1.11.3. Profitability by Market Segments 19.1.11.4. Sales Footprint 19.1.11.5. Strategy Overview 19.1.11.5.1. Marketing Strategy 19.1.12. Kawasumi Laboratories Inc. 19.1.12.1. Overview 19.1.12.2. Product Portfolio 19.1.12.3. Profitability by Market Segments 19.1.12.4. Sales Footprint 19.1.12.5. Strategy Overview 19.1.12.5.1. Marketing Strategy 19.1.13. Therakos Incorporation 19.1.13.1. Overview 19.1.13.2. Product Portfolio 19.1.13.3. Profitability by Market Segments 19.1.13.4. Sales Footprint 19.1.13.5. Strategy Overview 19.1.13.5.1. Marketing Strategy 20. Assumptions & Acronyms Used 21. Research Methodology
Explore Healthcare Insights
View Reports